Results 81 to 90 of about 1,100,780 (314)

Swiss survey on hybrid imaging CTs doses in Nuclear Medicine and proposed national dose reference levels

, 2018
A multidisciplinary working group led by the Swiss Federal Office of Public Health was formed to plan and perform a nationwide survey of patient radiation exposure from computed tomography (CT) in hybrid devices across Nuclear Medicine departments.
Reto Linder, Nicolas Stritt, Stritt, N., Stritt, Nicolas, Strobel, K., Lima, Thiago V.M., Thiago V.M. Lima, Klaus Strobel, Gnesin, Silvano, Gnesin, S., Linder, Reto, Lima, TVM, Linder, R., Nick Ryckx, Ryckx, Nick, Silvano Gnesin, Ryckx, N., Strobel, Klaus   +17 more
core   +1 more source

Expert consensus of ¹⁷⁷Lu-labeled PSMA radioligand therapy for clinical practice of prostate cancer (2024 edition)

Zhongguo aizheng zazhi
177Lu-labeled prostate-specific membrane antigen radioligand therapy (177Lu-PSMA-RLT) is an innovative treatment approach that precisely delivers β radiation emitted by 177Lu to prostate cancer cells, causing radiation damage to the tumor cells’ DNA and ...
Nuclear Medicine Committee of China Anti-Cancer Association Cancer, Association of Nuclear Medicine Physicians Chinese   +1 more
doaj  

E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer

Molecular Oncology, EarlyView.
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov, Shiva Krishna Katkam, Zhefan Wang, Venkateshwar G. Keshamouni   +3 more
wiley   +1 more source

Development of Scintillators in Nuclear Medicine

World Journal of Nuclear Medicine, 2015
High-quality image is necessary for accurate diagnosis in nuclear medicine. There are many factors in creating a good image and detector is the most important one. In recent years, several detectors are studied to get a better picture.
Mohammad Khoshakhlagh, Jalil Islamian, Seyed Abedi, Babak Mahmoudian   +3 more
doaj   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Physics in nuclear medicine

, 2012
Physics in Nuclear Medicine - by Drs. Simon R. Cherry, James A. Sorenson, and Michael E. Phelps - provides current, comprehensive guidance on the physics underlying modern nuclear medicine and imaging using radioactively labeled tracers. This revised and
Sorenson, James A., Phelps, Michael E, Cherry, Simon R., Cherry, Simon R, Sorenson, James A, Phelps, Michael E.   +5 more
core  

Informed Consent in the Nuclear Medicine Setting

, 2011
In the nuclear medicine setting, the task of obtaining informed consent for procedures that require it is frequently left to the nuclear medicine technologist.
M. S. Rosenthal, Rosenthal, M Sara
core   +1 more source

Euro-American discussion document on entry and advanced level practice in nuclear medicine [PDF]

, 2011
The European Association of Nuclear Medicine Technologist Committee (EANMTC) and the Society of Nuclear Medicine Technologist Section (SNMTS) meet biannually to consider matters of mutual importance. These meetings are held during the SNM and EANM annual
Hogg, P, Medvedec, H, Waterstram-Rich, K, Testanera, G   +3 more
core   +1 more source

Thai Guideline for Nuclear Medicine Investigations of Neurocognitive Disorders: Nuclear Medicine Society of Thailand, the Neurological Society of Thailand, and Thai Medical Physicist Society Collaboration

Diagnostics
Nuclear medicine investigations play a significant role in diagnosing dementia, mainly using imaging techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT).
Tawika Kaewchur, Tanyaluck Thientunyakit, Wichana Chamroonrat, Benjapa Khiewvan, Peerapon Kiatkittikul, Nantaporn Wongsurawat, Chanisa Chotipanich, Yuttachai Likitjaroen, Vorapun Senanarong, Panya Pasawang, Tanawat Sontrapornpol, Nucharee Poon-iad, Sasithorn Amnuaywattakorn, Supatporn Tepmongkol   +13 more
doaj   +1 more source

Melanoma & nuclear medicine: new insights & advances

Melanoma Management, 2018
The contribution of nuclear medicine to management of melanoma patients is increasing. In intermediate-thickness N0 melanomas, lymphoscintigraphy provides a roadmap for sentinel node biopsy.
Andrés Perissinotti, Daphne DD Rietbergen, Sergi Vidal-Sicart, Ana A Riera, Renato A Valdés Olmos   +4 more
doaj   +1 more source